drugset / Trial / NCT05237791

Effect of Magnesium on Remifentanil Induced Cough

NCT05237791

Phase 4 Unknown 78 enrolled Seoul National University Bundang Hospital
RandomizedParallel-groupTriple-blindPrevention

Summary

The hypothesis of this study is that Magnesium sulfate pretreatment (50mg/kg) will reduce the incidence of cough and chest wall rigidity caused by remifentanil administration. The purpose of this study was to investigate the effect of magnesium sulfate administered before induction of anesthesia on thoracic stiffness and cough response caused by opioid analgesics administered for general anesthesia.

Timeline

Start
2022-02-03
Primary completion
2022-06-30
Completion
2022-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Magnesium Sulfate Other / unclassified 15 mg/kg

Indications

No indication recorded.